MedPath

The Efficacy of a RAGT & BWSTT on Children With CP

Not Applicable
Completed
Conditions
Cerebral Palsy
Interventions
Device: Body weight supported treadmill training
Device: Robotic assisted gait training
Registration Number
NCT06368180
Lead Sponsor
King Saud University
Brief Summary

This study compared the effects of Robotic-assisted Gait Training (RAGT) and body weight support treadmill training (BWSTT) on spatio-temporal gait parameters and walking capacity among ambulatory children with bilateral Cerebral Palsy (CP)

Detailed Description

Demographic data were collected from patient medical records in the physiotherapy clinic at King Abdullah Specialist Children's Hospital and by completing the screening sheet . There were two intervention groups in this study. The first group received Robotic-assisted Gait Training (RAGT), while the second group received body weight support treadmill training (BWSTT). All participants from both intervention groups performed the home exercise program. All participants received 24 sessions three times per week over 8 weeks. Some participants were absent from some treatment sessions, either because they were suffering from flu, for reasons related to school, or other reasons. These participants were compensated with other sessions. Outcome measurements were assessed by a physiotherapist blinded to the group allocations. A physiotherapist assessed the participants at baseline and after treatment (at the end of 8 weeks)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Children aged from 5 to 14 years with bilateral spastic Cerebral palsy (CP) diagnosed by a pediatrician.
  • Gross Motor Function Classifications (GMFCS); levels I (walks without limitation), II (walks with limitation), and III (walks using assistive devices).
  • Able to follow instructions and accurately signal pain and discomfort.
  • Hip and knee passive Range of Motion (ROM) within the minimum range requirement for Robotic-assisted Gait Training (RAGT) (≤ 10⁰ for hip and knee flexion contracture and ≤ 40⁰ for knee valgus).
Exclusion Criteria
  • Botox injection for lower limb within the past 4 to 6 months.
  • Surgical intervention for lower limbs within an 8-month period before the examination date, including tendon release and muscle lengthening in a 1-year period prior to bone surgery.
  • Children using an active drug for resisting epilepsy.
  • Anatomical leg length difference greater than 2 centimeters (due to the limitations of the RAGT system).
  • Bone-articular instability (joint dislocation).
  • Fixed joint contractures (bone and joint deformity).
  • Baclofen therapy with the use of an implanted infusion pump.
  • Inhibited cast for a lower limb within 6 months of the study.
  • Significant amblyopia and hearing loss.
  • Skin inflammation and open skin lesion around the limb or trunk.
  • Significant impairments in endurance due to a limitation in the cardiovascular system based on the patient's history.
  • Maximum child weight is 135 kilograms and maximum height is 2.0 meters.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Body weight support treadmill training groupBody weight supported treadmill trainingThis group had gait training using while the participant's body weight was supported over the treadmill by the Biodex Unweighting System.
Robotic assisted gait training groupRobotic assisted gait trainingThis group had gait training using a robotic treadmill training system that uses body weight support belt, and driven gait orthoses (pediatric orthoses) for both legs.
Primary Outcome Measures
NameTimeMethod
Gait spatio-temporal parameters1 minute

The Zebris gait analysis system was used in this study to obtain gait spatio-temporal parameters in children with CP. The Zebris gait analysis system consists of a platform that has a sensing area of 200 × 60 cm.

Secondary Outcome Measures
NameTimeMethod
Six-minute walk test (6MWT)6 minutes

The 6MWT is a standardized walking test used to assess walking capacity in ambulatory children with CP. It is valid and reliable for children and adolescents who have CP and are healthy

Trial Locations

Locations (1)

King Abdu Aziz Medical City

🇸🇦

Riyadh, Saudi Arabia

King Abdu Aziz Medical City
🇸🇦Riyadh, Saudi Arabia
© Copyright 2025. All Rights Reserved by MedPath